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ABSTRACT
Anderson-Fabry’s disease (AFD) is a rare, X-linked lysosomal storage disorder caused by the complete deficiency or attenuated activity of 
the enzyme α-galactosidase A, leading to progressive systemic intracellular accumulation of glycosphingolipids and subsequent cellular 
dysfunction, inflammation and fibrosis. Fever is a frequently misinterpreted symptom in the early stages of the disease, leading to diagnostic 
delay. We present the case of a 35-year-old man admitted to our Periodic Fever Research Centre for long-lasting recurrent episodes of fever 
of unknown origin. After extensive assessment, we diagnosed AFD associated with a novel GLA mutation. We started enzyme replacement 
therapy with clinical benefit and complete remission of fever. 
LEARNING POINTS
• Anderson-Fabry’s Disease (AFD) is an inherited lysosomal storage disorder, in which progressive multi-organ glycosphingolipid 
accumulation leads to multi-systemic dysfunction. Diagnosis requires a high level of suspicion as the clinical presentation can be very 
heterogeneous.
• As fever is an early uncommon symptom causing diagnostic delay, it is important to consider AFD in the differential diagnosis of 
recurrent fevers, particularly when febrile episodes are not associated with an increase in acute phase reactants and when other signs 
or symptoms suggestive of AFD are present. 
• Prognosis depends on an early diagnosis because promptly initiation of enzyme replacement therapy (ERT) can prevent the progression 
of organ damage.In our case fever disappeared after ERT initiation, a finding not previously reported to our knowledge. Therefore, fever 
remission could be an early marker of response to ERT.
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CASE DESCRIPTION
A 35-year-old Italian man was referred to our Periodic Fever Research Centre in October 2013 for fever of unknown origin. He had normal 
physical and mental development and had received all recommended vaccinations during childhood. He had no history of major diseases and 
had never travelled in foreign countries. His family history was otherwise unremarkable. 
The patient reported he had experienced prolonged recurrent fevers since 5 years of age, lasting 5–10 days on average and with a frequency 
of five to six episodes per year. Fever was often preceded by prodromal symptoms such as headache, fatigue and asthenia, and was 
associated with nausea, abdominal pain and sometimes diarrhoea. The patient had been treated with anti-inflammatory drugs and different 
combinations of wide-spectrum antibiotic drugs, with no clinical benefit.He had also received steroid treatment (prednisone 5 mg/day) with 
transient disappearance of fever, but with prompt relapse on steroid discontinuation.
On July 2013, due to a new, long-lasting episode of such fever, he was admitted to a local hospital, where a complete multi-organ evaluation 
was performed. Blood count, electrolytes, liver, kidney and thyroid function as well as protein electrophoresis and inflammatory markers 
(CRP, ESR, B2-microglobulin, fibrinogen, ferritin) were all normal. Screening for autoimmune disorders (including RF, c-ANCA, p-ANCA, 
ANA, anti-ENA, complement components, anti-thyroglobulin) was negative. Haematological disorders and malignancies were ruled out 
after bonemarrow biopsy, thoraco-abdominal, head and neck CT scans, and abdominal, prostate and testicular ultrasound. Infectious and 
parasitic diseases were ruled out by negative serology for CMV, EBV, HIV, toxoplasma, adenovirusand enterovirus, and negative Widal–
Wright and Weil–Felix reactions. Infective endocarditis was excluded by negative blood cultures and transthoracic echocardiography,while 
central fever was ruled out by brain MRI.
After this extensive screening, the patient was transferred to our hospital for further investigationof the aetiology of his fever. At evaluation, 
the patient was afebrileand in good general condition, and his physical examination was normal.
During detailed investigation of the symptoms associated with fever, the patient stated that febrile episodes were occasionally associated 
with acroparesthesias, described as burning and numbness sensations in the extremities with centripetal progression. In addition, in 2007 
the patient had experienced acute transient hearing loss and tinnitus in the right ear. A brain MRI performed at that time showed a small 
right temporal leptomeningeal cyst and dolichoectasia of the vertebrobasilar artery, and the patient was discharged with the diagnosis of 
‘bilateral perceptive hearing loss for high frequencies’. In 2012 he had an episode of objective vertigo associated with persistent tinnitus in 
the left ear.
Once we confirmed that the most common causes of fever could be safely excluded, molecular studies for anti-inflammatory fevers (MEFV, 
TRAPS, MVK) were performed, with negative results. The absence of inflammatory markers during febrile episodes supported this finding.
Taken together, recurrent febrile episodes with no increase in acute phase reactants, associated with abdominal pain, a history of 
acroparesthesias during childhood, the episodes of acute reduction in hearing acuity associated with tinnitus and the incidental finding of 
dolichoectasia of the vertebrobasilar artery, raised the suspicion of Anderson-Fabry’s disease (AFD).
Therefore, α-galactosidase activity in peripheral leukocyteswas measured and found to be very low (4.46±0.21 nmol/mg/h, normal range 
66.31–88.01). We then performed molecular analysis to confirm the AFD diagnosis and found hemizygosity for a novel GLA gene mutation 
c.907A>T (p.Ile303Phe; data not yet published). 
Soon after the diagnosis, extensive assessment of organ involvement was performed. Cardiac evaluation revealed a nearly normal ECG, but 
the echocardiogram showed mild biventricular hypertrophy.
Other relevant findings were: kidney involvement, as shown by glomerular hyperfiltration (creatinine clearance 166 ml/min/1.73 m2, normal 
range 80–140) with no proteinuria and a normal kidney scan; ear involvement, with bilateral perceptive hearing loss for high frequencies; 
normal brain MRI except for the dolichoectasia of the vertebrobasilar artery (Fig.1A); and eye involvement, with evidence of bilateral retinal 
vessel tortuosity (Fig.1B). LysoGb3 levels were 23.6 ng/ml (normal value ≤0.8).
We started enzyme replacement therapy (ERT) and at 6-month follow-up the fever had subsided, paresthesias had improved substantially, 
and LysoGb3 levels were significantly decreased (14.1 ng/ml), while left ventricular hypertrophy remained stable. 
DISCUSSION
FD is a rare, X-linked, recessive lysosomal storage disorder caused by complete deficiency or attenuated activity of the enzyme α-galactosidase 
A, leading to progressive systemic intracellular accumulation of neutral glycosphingolipids, particularly globotriaosylceramide, with 
subsequent cellular dysfunction, inflammation and fibrosis.
In the classic phenotype, progressive glycosphingolipid accumulation in cardiac, renal and cerebrovascular cells leads to multi-organ 
dysfunction. During childhood, early symptoms are distal extremity pain, recurrent fever, hypo/anhydrosis and gastrointestinal distress. 
In advanced stages, multi-organ dysfunction causes considerable morbidity and premature death, mainly due to heart and kidney 
involvement [1, 2].
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Fever is a frequently misinterpreted symptom in the early stages of the disease, leading to diagnostic delay. The fever has been attributed to 
dysfunction of the sweat glands and the cholinergic system, resulting in impaired thermoregulation. A recent retrospective analysis by our 
group has demonstrated that a significant number of AFD patients presented with fever at the onset of the disease. In our analysis, fever was 
associated with a significant mean diagnostic delay of 15.8±12.8 years[3].
In this case the diagnostic delay was 29 years, which highlights the importance of considering AFD in the differential diagnosis of recurrent 
fever, particularly when febrile episodes are not associated with an increase in acute phase reactants and when other signs or symptoms 
suggestive of AFD are present. 
Prompt diagnosis allows the administration of specific therapy to modify the course of the disease. Early initiation of ERT can prevent 
progression to organ damage, stabilize the existing disease and prevent or delay major complications [4].
Figure 1 (A) Brain MRI showing dolichoectasia 
of the vertebrobasilar artery (white arrow), 
a characteristic finding of Anderson-Fabry’s 
disease. (B) Right ocular fundus showing 
increased retinal vessels tortuosity with a 
‘corkscrew’ appearance (white arrows).
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